Key result
Recurrent acute myocarditis linked to ~2.1-fold higher risk of major cardiovascular events.
Why the study?
Recurrence of acute myocarditis is challenging, and the management and natural history of patients experiencing recurrent acute myocarditis remain poorly characterized.
Does recurrent acute myocarditis increase the composite risk of all-cause mortality, heart transplant, and major ventricular arrhythmias in patients with acute myocarditis?
Cohort (n=513)
Yes
Does recurrent acute myocarditis increase the composite risk of all-cause mortality, heart transplant, and major ventricular arrhythmias in patients with acute myocarditis?
Recurrent acute myocarditis identifies a distinct, high-risk patient group characterized by significantly increased rates of major ventricular arrhythmias and adverse clinical outcomes, emphasizing the need for targeted surveillance.
Answers are grounded in this paper and cite their sources.
Recurrent myocarditis may warrant closer arrhythmia surveillance; leaves open whether targeted interventions improve outcomes in this observational cohort.
BACKGROUND: Recurrence of acute myocarditis (AM) is challenging. The management and natural history of patients who experience a recurrence of AM (Re-AM) remain poorly characterized. The aim of this study is to investigate clinical characteristics and outcomes of patients with Re-AM. METHODS: In this international multicenter study, 141 consecutive patients with biopsy-proven or cardiac magnetic resonance-proven Re-AM (35 [26-45] years, 77% male, median left ventricular ejection fraction 55%) were investigated and compared with 372 consecutive patients with single acute myocarditis (S-AM). The primary outcome was a composite of all-cause mortality, heart transplant and major ventricular arrhythmias. A family history of cardiomyopathy, autoimmune diseases, and ring-like late gadolinium enhancement was independently associated with a higher risk of recurrent AM. CONCLUSIONS: Re-AM is a distinct clinical subgroup of AM associated with generally worse prognosis and a specific increased arrhythmic risk compared with S-AM.
No takes yet. Share an insight, caveat, or question.
Baggio et al. (2026) conducted a cohort in Acute myocarditis (n=513). Recurrent acute myocarditis vs. Single acute myocarditis was evaluated on Composite of all-cause mortality, heart transplant, and major ventricular arrhythmias (HR 2.15, 95% CI 1.15-4.04, p=0.017). Recurrent acute myocarditis was independently associated with a more than two-fold higher risk of a composite of all-cause mortality, heart transplant, and major ventricular arrhythmias compared with single-episode myocarditis.
Synapse has enriched 10 related papers. Consider them for comparative context: